Promoting the expression of CYP2S1 can enhance the effect of oxaliplatin on COAD cells, while knocking down CYP2S1 can promote the expression of prostaglandin E2, thus promoting tumor proliferation (26, 27). This evidence concerns the gene CYP2S1 and neoplasm.